BBOT stock news
This page provides real-time market news, earnings updates, and company announcements related to BridgeBio Oncology Therapeutics, Inc. (BBOT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-14 03:02 EST
Switzerland Postpones Crypto Tax Data Exchange to Meet Technological and International Requirements
Bitget-RWA2025-11-28 03:56:17
Kailera’s Ron Renaud discusses how a startup with connections to China can stand out in the obesity market
101 finance2026-01-20 12:09:29
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
BridgeBio Nears 52-Week High On Strong Dwarfism Trial Data, Plans FDA Filing In 2026
Finviz2026-02-12 17:48:41
BBOT stock chart
BBOT stock detailsBBOT stock price change
On the last trading day, BBOT stock closed at 11.14 USD, with a price change of -2.45% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more